SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Barry Dryer who wrote (373)3/11/1999 3:02:00 PM
From: Todd D. Wiener  Read Replies (1) | Respond to of 420
 
Barry-

I haven't been closely following NOV recently, but I'm not interested in them. The large amount of debt makes the current stock price much less attractive than it appears to be. Most importantly, there are too many other undervalued stocks that have strong businesses and no debt, so NOV would be far down on my list.

Todd



To: Barry Dryer who wrote (373)4/13/1999 2:09:00 AM
From: Pe@cockm@n  Read Replies (2) | Respond to of 420
 
I agree and am holding for long term gains. Bear Stearns has a report that basically says that the breakup value is around $4.50. With book at around $9.00 and sales of assets I think that we will see a nice turnaround soon.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News